Ticker: OVID

Company: Ovid Therapeutics Inc.

Person: STELIOS PAPADOPOULOS, director

Transaction date: April 7, 2026

Reporting date: April 9, 2026

Average share price: 2.56

Bought 17578.0 shares for 44999.68